×
About 4,428 results

ALLMedicine™ Conjunctiva Center

Research & Reviews  1,437 results

Retrobulbar Block
https://emedicine.medscape.com/article/2000744-print

May 19th, 2022 - Background Retrobulbar block is type of regional anesthetic nerve block used in intraocular surgery. In this technique, local anesthetic is injected into the retrobulbar space, the area located behind the globe of the eye. This injection provides ...

Retrobulbar Block
https://emedicine.medscape.com/article/2000744-overview

May 19th, 2022 - Overview Background Retrobulbar block is type of regional anesthetic nerve block used in intraocular surgery. In this technique, local anesthetic is injected into the retrobulbar space, the area located behind the globe of the eye. This injection ...

Associations Between Lid Wiper Microvascular Responses, Lens Fit, and Comfort After One...
https://doi.org/10.1097/ICL.0000000000000898
Eye & Contact Lens; Jiang H, Fang M et. al.

May 18th, 2022 - To determine associations between lid wiper microvascular responses, lens fit, and comfort after 1 day of contact lens adaptation by neophytes. Functional slitlamp biomicroscopy was used to image the microvascular network of the upper tarsal conju...

Refill-Exchange Procedure of the Port Delivery System With Ranibizumab: Overview and Cl...
https://doi.org/10.3928/23258160-20220412-01
Ophthalmic Surgery, Lasers & Imaging Retina; Khanani AM, Graff JM et. al.

May 17th, 2022 - To describe the Port Delivery System with ranibizumab refill-exchange procedure. Procedure based on the clinical trial program in patients with retinal diseases. The refill-exchange procedure is performed under topical anesthesia and strict asepti...

see more →

Guidelines  1 results

COVID-19 vaccine anaphylaxis: IgE, complement or what else? A reply to: "COVID-19 vaccine anaphylaxis: PEG or not?"
https://europepmc.org/article/pmc/pmc8441702
Allergy Cabanillas B, Akdis CA et. al.

Jun 21st, 2021 - Thank you for the correspondence of Krantz et al “COVID‐19 vaccine anaphylaxis: PEG or not?”.1 We totally agree with the authors that patients previously allergic to polyethylene glycol (PEG) might react to PEGylated liposomes when exposed to t...

see more →

Drugs  147 results see all →

Clinicaltrials.gov  67 results

Micro-Conjunctival Autografting Combined With Amniotic Membrane Transplantation Treating Recurrent Pterygium Trial
https://clinicaltrials.gov/ct2/show/NCT05362253

May 5th, 2022 - Recurrent pterygium is a common postoperative complication of pterygium surgery, the postoperative recurrence rate is about 1.44% and needs careful treatment. At present, surgical is the main and most effective treatment of recurrent pterygium. Am...

Ologen® Collagen Matrix in Patients With Primary Congenital Glaucoma Undergoing Trabeculectomy
https://clinicaltrials.gov/ct2/show/NCT03541551

Apr 12th, 2022 - Standard combined trabeculectomy with trabeculotomy (CTT) All CTT surgeries will be performed under general anesthesia.Under aseptic surgical technique, a superior rectus suture will be placed using 4'0 silk and a limbal-based conjunctival flap to...

Evaluation of 0.05% CsA and 0.1% FK506 Eye Drops in Ocular GVHD Treatment
https://clinicaltrials.gov/ct2/show/NCT05294666

Mar 24th, 2022 - Chronic graft-versus-host disease (GVHD) is a common and serious complication after allogeneic hematopoietic stem cell transplantation. Its clinical presentation is similar to that of an autoimmune disease and can affect many organs, including the...

Study on Precision Treatment of Diabetic Retinopathy Macular Edema Guided by Real-time OCT During Operation
https://clinicaltrials.gov/ct2/show/NCT05138029

Mar 8th, 2022 - Test method: Include suitable cases of diabetic retinopathy and macular edema Inclusion criteria: a. PDR patients with severe vitreous hemorrhage who cannot collect oct images and require vitrectomy b. Type 2 diabetes, aged 18~80 years old c. Good...

Inflammatory Biomarkers in Ocular Surface in Primary Open Angle Glaucoma or Ocular Hypertension Under Topical Prostaglandins
https://clinicaltrials.gov/ct2/show/NCT05039684

Jan 31st, 2022 - Glaucoma is a chronic optic neuropathy whose main modifiable risk factor is an abnormally elevated intraocular pressure. The aim of glaucoma treatment is to slow the progression of the disease by reducing intraocular pressure. Prostaglandin deriva...

see more →

News  110 results

Unilateral eye irritation
https://www.mdedge.com/familymedicine/article/254196/unilateral-eye-irritation
MDedge Family Medicine;

Apr 28th, 2022 - Physical examination revealed an irregularly shaped conjunctival cyst on the lateral (temporal) field of the right eye. (This diagnosis is usually made based on the clinical examination alone.

Safety of Belantamab Mafodotin in Patients With RRMM
https://www.onclive.com/view/safety-of-belantamab-mafodotin-in-patients-with-rrmm

Mar 8th, 2022 - Sagar Lonial, MD, FACP: I’m going to turn to Dr Klugo for a moment to ask a couple of questions about some of the unique adverse events that we see when patients receive belantamab mafodotin. Dr Klugo, what’s unique about belamaf [belantamab mafod...

Cervical Cancer Treatment Paradigm Is Bolstered With Newly Approved Therapies
https://www.onclive.com/view/cervical-cancer-treatment-paradigm-is-bolstered-with-newly-approved-therapies

Jan 28th, 2022 - Treatment of patients with metastatic cervical cancer remains challenging—the 5-year overall survival (OS) rate is just 17%.1 Whereas many other solid tumors have seen a plethora of FDA approvals of clinically meaningful treatments, there has been...

First Implant Approved for Wet Macular Degeneration
https://www.medscape.com/viewarticle/961623

Oct 26th, 2021 - The US Food and Drug Administration for the first time approved an implant to treat neovascular age-related macular degeneration (nAMD). By releasing a constant dose of ranibizumab, the implanted port delivery system (Susvimo) made by Genentech/Ro...

FDA Approves Drugs for Wet AMD, Macular Edema Due to Uveitis
https://www.medscape.com/viewarticle/961565

Oct 25th, 2021 - Ophthalmologists in the US will soon have more options in their toolkit to manage neovascular age-related macular degeneration (AMD) and macular edema associated with uveitis. Susvimo, a 100 mg/mL ranibizumab injection for intravitreal use via ocu...

see more →

Patient Education  9 results see all →